Cajal Therapeutics Inc.: Clinical Trials

1 trial sponsored by Cajal Therapeutics Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Cajal Therapeutics Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
CTX001 With and Without Iron, CTX001 With Iron, CTX001 Multiple Dose - Anemia, Iron Deficiencies
Early Phase 1RecruitingCajal Therapeutics Inc.722026-06-012026-06-12

Conditions studied

Anemia (1)  ·  Iron Deficiencies (1)  ·  Renal Insufficiency, Chronic (1)

Interventions

Iron (1)  ·  exagamglogene autotemcel (1)

Countries

Australia (1)

Top investigators

Aarthy Joseph, Dr (1)